2026-09-24T06:25:33Zhttps://dspace.mit.edu/server/oai/requestoai:dspace.mit.edu:1721.1/80652022-01-13T07:54:49Zcom_1721.1_7582com_1721.1_7581col_1721.1_131022
David Mindell.
Hoyt, Kendall L. (Kendall Lindquist), 1971-
Massachusetts Institute of Technology. Program in Science, Technology and Society.
Massachusetts Institute of Technology. Program in Science, Technology and Society
2005-08-24T20:03:36Z
2005-08-24T20:03:36Z
2002
http://hdl.handle.net/1721.1/8065
51055743
Thesis (Ph. D.)--Massachusetts Institute of Technology, Program in Science, Technology and Society, June 2002.
"May 2002." Vita.
Includes bibliographical references (p. 193-205).
This thesis examines the historical conditions that have contributed to high rates of vaccine innovation in the U.S. during the twentieth century. Empirical analysis of vaccine license data demonstrates that the highest rates of innovation were achieved during the 1940's. Historical analysis of this data indicates that a large percentage of these innovations were the product of World War II vaccine development programs. Participation in these programs fostered a uniquely productive culture of collaboration between military and industrial vaccine developers that persisted through the postwar era, maintaining innovation rates through the 1960's and early 1970's. By the mid-1970's, however, the historical circumstances and cultural factors that engendered and sustained military-industrial collaboration began to change, causing rates of vaccine innovation to fall and vaccine stocks to dwindle. Poor economic incentives for vaccine development are often cited as the reason for falling rates of innovation. This explanation is correct but incomplete, because, for example, economic incentives for vaccine development were poor during the 1940's and 1950's, when innovation rates were high. I demonstrate that vaccine innovation is tied to levels of military-industrial collaboration and that declining rates of innovation in recent decades are associated with the disruption of this military-industrial culture of collaboration. Finally, drawing on lessons from this history of military-industrial relations, I examine the opportunities and challenges that the new "war on terrorism" presents for efforts to improve vaccine innovation and supplies.
Kendall L. Hoyt.
Ph.D.
227 p.
22367994 bytes
22367750 bytes
application/pdf
application/pdf
eng
Massachusetts Institute of Technology
M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.
http://dspace.mit.edu/handle/1721.1/7582
Program in Science, Technology and Society.
The role of military-industrial relations in the history of vaccine innovation
Thesis
application/pdf
false
Publication
unknown
unknown
<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="00fcbf0b-1fc8-4c37-908f-cab0a16b88d2">
<Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type>
<Language>eng</Language>
<Title>The role of military-industrial relations in the history of vaccine innovation</Title>
<PublishedIn>
<Publication>
</Publication>
</PublishedIn>
<PublicationDate>2002</PublicationDate>
<Authors>
<Author>
<DisplayName>Hoyt, Kendall L. (Kendall Lindquist), 1971-</DisplayName>
<Affiliation>
<OrgUnit>
</OrgUnit>
</Affiliation>
</Author>
</Authors>
<Editors>
</Editors>
<Publishers>
<Publisher>
<DisplayName>Massachusetts Institute of Technology</DisplayName>
<OrgUnit />
</Publisher>
</Publishers>
<License>http://dspace.mit.edu/handle/1721.1/7582</License>
<Keyword>Program in Science, Technology and Society.</Keyword>
<Abstract>This thesis examines the historical conditions that have contributed to high rates of vaccine innovation in the U.S. during the twentieth century. Empirical analysis of vaccine license data demonstrates that the highest rates of innovation were achieved during the 1940's. Historical analysis of this data indicates that a large percentage of these innovations were the product of World War II vaccine development programs. Participation in these programs fostered a uniquely productive culture of collaboration between military and industrial vaccine developers that persisted through the postwar era, maintaining innovation rates through the 1960's and early 1970's. By the mid-1970's, however, the historical circumstances and cultural factors that engendered and sustained military-industrial collaboration began to change, causing rates of vaccine innovation to fall and vaccine stocks to dwindle. Poor economic incentives for vaccine development are often cited as the reason for falling rates of innovation. This explanation is correct but incomplete, because, for example, economic incentives for vaccine development were poor during the 1940's and 1950's, when innovation rates were high. I demonstrate that vaccine innovation is tied to levels of military-industrial collaboration and that declining rates of innovation in recent decades are associated with the disruption of this military-industrial culture of collaboration. Finally, drawing on lessons from this history of military-industrial relations, I examine the opportunities and challenges that the new "war on terrorism" presents for efforts to improve vaccine innovation and supplies.</Abstract>
<Access xmlns="http://purl.org/coar/access_right"
>
</Access>
</Publication>